Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:RMD Open
Autori principali: Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2015
Soggetti:
Paediatric Rheumatology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://ncbi.nlm.nih.gov/pubmed/26509061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000036
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi